Pfizer CEO Bourla Expected To Announce A $70 Billion Investment On Manufacturing Medications In The United States - WSJ

ReutersSep 30, 2025 2:19 PM

View all comments（0）



Sept 30 (Reuters) -

PFIZER CEO BOURLA EXPECTED TO ANNOUNCE A $70 BILLION INVESTMENT ON MANUFACTURING MEDICATIONS IN THE UNITED STATES - WSJ
WHITE HOUSE TO ANNOUNCE ‘TRUMPRX’ DRUG-BUYING WEBSITE - WSJ
TRUMPRX WOULD ALLOW PEOPLE TO PAY CASH FOR CERTAIN DRUGS DIRECTLY FROM A GOVERNMENT WEBSITE, AT A DISCOUNTED PRICE NEGOTIATED BY GOVERNMENT - WSJ

Source: https://tinyurl.com/2xb4y3m6

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Japan and South Korea Stocks Rise in Early Trade, Samsung Rebounds Over 3%, Trump Arrives in Beijing With Tech Giants

TradingKey - Asian stock markets generally trended higher in Thursday morning trading. The Nikkei 225 opened 0.14% higher, with intraday gains expanding to 200 points at one stage, while SoftBank Group tracked the advance with a gain of over 1%. South Korea’s KOSPI opened 0.4% higher and rallied quickly, with intraday gains reaching 1% and surpassing the 7,900-point mark. LG Electronics led the index constituents, rising more than 5%.

Today’s Market Recap: Tech-Led Rally Drives Record Highs as Trump Arrives in Beijing

Tech-driven gains pushed the S&P 500 and Nasdaq to record highs as President Trump arrived in Beijing alongside Nvidia's CEO. Despite surging PPI data fueling rate-hike fears, strong AI-related growth from Cisco and Alibaba, plus Cerebras Systems' massive IPO demand, sustained investor optimism acro

Anthropic in Talks for Massive $30 Billion Funding, Valuation May Join Trillion-Dollar Ranks

TradingKey - On May 12, Eastern Time, Bloomberg reported that AI startup Anthropic is in preliminary discussions with investors to raise at least $30 billion in new capital at a pre-money valuation exceeding $900 billion. If the deal is finalized, it would mark the company's largest funding round to

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

TradingKey - Cerebras Systems (CBRS) IPO prices May 13–14 at $125–$135/share. $26–$27B valuation, 20x oversubscribed, $510M revenue, 47% net margin, OpenAI 750MW deal. Everything you need to know.

AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

TradingKey - On May 5 (ET), Advanced Micro Devices (AMD) released its first-quarter fiscal 2026 financial results after the market close. The company reported revenue of $10.253 billion, up 38% year-over-year, exceeding market expectations of $9.89 billion. Non-GAAP earnings per share (EPS) were $1.

Featured Tools